Sodium-glucose co-transporters are responsible for 97% of glucose reabsorption6 and their inhibition lowers blood glucose by increasing renal glucose excretion.4 , 5 Using SGLT-2 inhibitors increases the risk of DKA6 , 7 by decreasing daily carbohydrate availability by 20%45%,9 lowering endogenous insulin production and stimulating lipolysis that leads to ketogenesis.6 Patients who also receive insulin may decrease insulin doses in response to lower blood glucose patterns, leading to insulin deficiency
Compounded medication considerations Compounded GLP-1 medications are not FDA-approved products
Our field service team ensures your sensors and cables are installed and functioning correctly
How Therapy Can Help You Better Manage Stress In this expert guide, learn how therapy can help you manage stress with mindfulness, boundaries, and healthy habits
[DOI] [PubMed] [Google Scholar] 310.Yin Z
To Support Proper L-Carnitine Levels: For individuals with carnitine deficiencies or diets insufficient in carnitine (e.g
